- Home
- KROS vs RMAX Comparison
KROS vs RMAX Comparison
Compare KROS & RMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KROS | RMAX |
|---|---|---|
| Founded | 2015 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.3M | 199.2M |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | KROS | RMAX |
|---|---|---|
| Price | $10.75 | $9.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $21.86 | $11.40 |
| AVG Volume (30 Days) | 312.7K | ★ 523.9K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.00 | N/A |
| EPS | N/A | ★ 0.60 |
| Revenue | ★ $243,864,000.00 | $195,929,000.00 |
| Revenue This Year | N/A | $2.62 |
| Revenue Next Year | $2,751.79 | $1.24 |
| P/E Ratio | ★ N/A | $15.35 |
| Revenue Growth | N/A | ★ 11.13 |
| 52 Week Low | $9.79 | $5.46 |
| 52 Week High | $22.55 | $11.62 |
Technical Indicators
Market Signals| Indicator | KROS | RMAX |
|---|---|---|
| Relative Strength Index (RSI) | 42.74 | 52.12 |
| Support Level | $10.47 | $8.88 |
| Resistance Level | $12.43 | $9.65 |
| Average True Range (ATR) | 0.64 | 0.42 |
| MACD | 0.01 | -0.13 |
| Stochastic Oscillator | 43.69 | 45.54 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About RMAX RE/MAX Holdings Inc.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.